Free Newsletter
Ontario earmarks $100M for gene research
Even as Canada's biotech industry struggles to survive a savage liquidity crisis, the Ontario government has set aside $100 million to fund new gene-related research work.
Research and Innovation Minister John Wilkinson says that the money will most likely be earmarked for specific projects by the end of this year, with "collaborative, transformational and internationally significant" programs getting first priority. The money will be granted through a peer-reviewed process.
The Ontario government says that it hopes the funds will stimulate basic biomedical research work, which in turn will lead to new therapies. And it says that the money should go a long way to retain and recruit top talent in the gene research field.
"It's a sizeable investment and one that will really make a difference," said Janet Rossant, a senior scientist and research chief at the Hospital for Sick Children. "It does signal that Ontario understands the importance of investing in research."
- read the report from HealthZone
Related Articles:
Survey: Canada needs to reinvest in life sciences
New survey paints bleak picture for Canada's biotech industry
Canadian biotechs short on cash
Investors turn cold shoulder to Canadian biotechs
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




